接头 CAR 共表达在淋巴瘤单一及双重抗原丢失后保留 CAR-T 细胞疗效 Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma. PubMed 2025/10/24 发表Mol TherQ1 · IF 11.4(JCR 2025) 靶点:CD19靶点:CD20靶点:ROR1技术:CAR-T技术:双特异性抗体淋巴瘤
RORing CAR-T 细胞在实体瘤与血液肿瘤中:相同却不同 RORing CAR T Cells in Solid and Hematologic Cancers: Same but Different. PubMed 2025/02/03 发表Clin Cancer ResQ1 · IF 10.9(JCR 2025) 靶点:ROR1技术:CAR-T乳腺癌慢性淋巴细胞白血病非小细胞肺癌地区:欧洲
各种成人白血病和淋巴瘤类型中 ROR1 水平的肿瘤评估 Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types. PubMed 2024/11/04 发表PLoS OneQ2 · IF 2.8(JCR 2025) 靶点:ROR1技术:CAR-T弥漫大B细胞淋巴瘤乳腺癌急性髓系白血病地区:欧洲地区:美国
全转录组测序揭示套细胞淋巴瘤中与癌症相关、具有预后意义的转录本及肿瘤浸润免疫细胞 Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lympho PubMed 2022/10/27 发表CellsQ2 · IF 6(JCR 2025) 靶点:ROR1技术:NK 细胞套细胞淋巴瘤非霍奇金淋巴瘤地区:欧洲
复发/难治性套细胞淋巴瘤的治疗选择 Therapeutic options for relapsed/refractory mantle cell lymphoma. PubMed 2022/02/03 发表BloodQ1 · IF 23.9(JCR 2025) 靶点:CD19靶点:ROR1技术:CAR-T技术:双特异性抗体套细胞淋巴瘤非霍奇金淋巴瘤